Impact of adjuvant treatments on survival in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup study.
Koo T, Lim DH, Seol HJ, Dho YS, Kim IH, Chang JH, Lee J, Jung TY, Gwak HS, Cho KH, Hong CK, Lee IJ, Kim E, Kim JH, Hong YK, Jang HS, Kim CY, Kim IA, Kim SH, Kim YI, Kim EY, Kim WC, Hong S.
Koo T, et al.
J Neurooncol. 2018 Nov;140(2):445-455. doi: 10.1007/s11060-018-2972-8. Epub 2018 Aug 10.
J Neurooncol. 2018.
PMID: 30097825